Author:
Shahi Farhad,Gorji Mojtaba,Payandeh Mehrdad,Rezvani Hamid,Vaezi Mohammad,Seifi Sharareh,Baari Alireza,Khalili-Dizaji Reza,Hashemi Seyed Mehdi,Salimi Saeid,Kamranzadeh Hosein,Shazad Babak,Salari Sina,Dameshghi Davoud Oulad,Sarkheil Mehdi,Mirzania Mehrzad,Anjidani Nassim
Subject
Pharmacology (medical),Pharmacology
Reference35 articles.
1. U.S. Food and Drug Administration. 2020. Postmarket Drug Safety Information For Patients And Providers. [online] Available at: [Accessed 2 August 2020].
2. Oxaliplatin: mechanism of action and antineoplastic activity;Raymond;Seminars in oncology,1998
3. Juniewicz P. Sequence-and region-specificity of oxaliplatin adducts in naked and cellular DNA;Woynarowski;Molecular pharmacology,1998
4. Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers;Raymond;Anti-cancer drugs,1997
5. Evaluation of in vitro cytotoxicity of oxaliplatin and 5-fluorouracil in human colon cancer cell lines: combination versus sequential exposure;Failli;Journal of biological regulators and homeostatic agents,2011
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献